Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M A, Cukierski"'
Autor:
K. I. Mackenzie, L. F. Kruk, M. A. Cukierski, Alice F. Tarantal, G. L. Skiles, A. P. Clarke, G. S. Harris, K. P. Ellsworth, C. P. Peter, Andrew G Hendrickx, D. S. Ablin, M. J. Vanzwieten, S. Prahalada
Publikováno v:
Teratology. 55:119-131
In genetic male fetuses, dihydrotestosterone (DHT) plays an important role in normal prostatic and external genital differentiation. The enzyme steroid 5-alpha reductase (5 alpha R) catalyzes the conversion of testosterone (T) to DHT. The importance
Publikováno v:
Primates. 37:351-361
The external characteristics and successive morphological changes of the brain and its derivatives were studied in 69 long-tailed monkey embryos representing developmental stages 8 through 16. This morphogenesis follows a similar pattern to those of
Publikováno v:
Journal of Medical Primatology. 25:122-132
Formation of the definitive kidney in Macaca fascicularis embryos was investigated using light and electron microscopy. Appearance of the definitive kidney at stage 14 was indicated by the ureteric bud invading the metanephrogenic blastema. Glomerula
Publikováno v:
Teratology. 51:383-397
Losartan, an AT1-selective angiotensin II receptor antagonist, was evaluated in female rats for effects on fertility, reproduction, and perinatal and postnatal development. In a range-finding study, pregnant rats were treated orally from gestation da
Autor:
R. S. Eydelloth, Jeanne M. Manson, Richard T. Robertson, Henry L. Allen, Stan Spence, M. A. Cukierski
Publikováno v:
Teratology. 51:367-382
Previous developmental and reproductive toxicity studies conducted in rats with Losartan, a potent AT1 subtype selective angiotensin II receptor antagonist, noted treatment-related effects on the pups of dams treated beyond the second trimester throu
Publikováno v:
Neonatology. 68:62-74
Porcine growth hormone was given subcutaneously twice daily to two groups of 20 females at dose levels of 0.5 and 2.5 IU/kg (1 and 5 IU/kg/day). A control group of 20 females was similarly treated with vehicle. The females were given either vehicle o
Autor:
C. J. Woyden, M. J. Novy, Mark G. Bock, Bradley V. Clineschmidt, B. E. Evans, E V Lis, Terry W. Schorn, K. L. Thompson, Peter K. S. Siegl, Douglas J. Pettibone, Duane R. Reiss, Peter D. Williams, Doug W. Hobbs, M. A. Cukierski, Maribeth T. Guidotti, Roger M. Freidinger, D. F. Veber, G. J. Haluska, M. J. Cook, M. J. Kaufman, S.-H. L. Chiu
Publikováno v:
Drug Development Research. 30:129-142
L-368,899 [1S-(-7,7-dimethyl-2-endo-(2S-amino-4-(methylsulfonyl)butyramido)-bicyclo(2.2.1)-heptan-1-yl)methanesulfonyl)-4-(2-methylphenyl)piperazine] was characterized in vitro and in vivo as a potent and selective, orally bioavailable oxytocin (OT)
Autor:
S, Prahalada, L, Rhodes, S J, Grossman, D, Heggan, K P, Keenan, M A, Cukierski, C M, Hoe, C, Berman, M J, van Zwieten
Publikováno v:
The Prostate. 35(3)
In rats, the prostate is divided into three distinct lobes, and the lobes are dependent on androgens [testosterone (T) and dihydrotestosterone (DHT)] as trophic hormones. However, the reasons for the difference in the incidence of proliferative chang
Autor:
S, Prahalada, A F, Tarantal, G S, Harris, K P, Ellsworth, A P, Clarke, G L, Skiles, K I, MacKenzie, L F, Kruk, D S, Ablin, M A, Cukierski, C P, Peter, M J, vanZwieten, A G, Hendrickx
Publikováno v:
Teratology. 55(2)
In genetic male fetuses, dihydrotestosterone (DHT) plays an important role in normal prostatic and external genital differentiation. The enzyme steroid 5-alpha reductase (5 alpha R) catalyzes the conversion of testosterone (T) to DHT. The importance
Autor:
B V, Clineschmidt, D J, Pettibone, D R, Reiss, E V, Lis, G J, Haluska, M J, Novy, M J, Cook, M A, Cukierski, M J, Kaufman, M G, Bock
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 256(3)
Two cyclic hexapeptides unrelated in chemical structure to oxytocin (OT) were shown in vivo to be antagonists of the contractile action of OT on the uterus. In anesthetized rats challenged with OT (1 micrograms/kg) administered as an i.v. bolus, L-36